human myoblasts therapy (Luogai Myoblast Medical Research Institute Wuhan)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman myoblasts therapy (Luogai Myoblast Medical Research Institute Wuhan)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDepressionPainDiabetes Mellitus +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesLuogai Myoblast Medical Research Institute Wuhan Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLuogai Myoblast Medical Research Institute Wuhan Co Ltd
Active IndicationsN/A
Inactive IndicationsDepressionPainDiabetes Mellitus +[5] 

Other Information

ATC CodeN/A
Related LinksN/A